proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action
Michel Thibault(Inserm), Nicolas Vodovar(Institut Pasteur), Malha Sadoune(Inserm), Alain Cohen‐Solal(Inserm), Damien Logeart(Inserm), Hélène Nougue(Délégation Paris 5), Jérôme Cartailler(Inserm), François Picard(Université de Bordeaux), Jean‐Marie Launay(Université Claude Bernard Lyon 1), Guillaume Lefèvre(Université de Lille)
Cited by 8
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
|European Journal of Preventive Cardiology|2020|924
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837